1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Bone Marrow Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Chen, Y; Feng, Y; Liu, H; Liu, L; Qiu, L; Wang, L; Wang, Q; Wang, Y | 1 |
| Mårtensson, L; Nilsson, R; Ohlsson, T; Sjögren, HO; Strand, SE; Tennvall, J | 1 |
2 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Bone Marrow Diseases
| Article | Year |
|---|---|
Safety and Efficacy of 68 Ga- or 177 Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases : A Phase 0/I Study.
Topics: Bone Marrow Diseases; Bone Neoplasms; Humans; Pain; Positron Emission Tomography Computed Tomography; Precision Medicine; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
Reduced myelotoxicity with sustained tumor concentration of radioimmunoconjugates in rats after extracorporeal depletion.
Topics: Adsorption; Animals; Antibodies, Monoclonal; Bone Marrow Diseases; Extracorporeal Circulation; Heterocyclic Compounds, 1-Ring; Immunoconjugates; Immunotoxins; Indium Radioisotopes; Neoplasm Transplantation; Neoplasms; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Inbred BN; Transplantation, Isogeneic | 2007 |